Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

SM-215 promotes hair growth by improving the environment around hair follicles.

SHBG may be a useful early indicator and treatment target for PCOS.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Stress can worsen skin conditions by affecting hormone levels and immune response.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Different types of stem cells in the skin contribute to the variety of melanoma forms.

Melatonin improved mental health and metabolism in women with PCOS.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.